U.S. Physical Therapy, Inc. (USPH)

NYSE: USPH · Real-Time Price · USD

82.96

-0.67 (-0.80%)

At close: Oct 7, 2026, 4:00 PM EDT

82.96

0.00 (0.00%)

After-hours: Oct 7, 2026, 4:10 PM EDT

U.S. Physical Therapy Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,238	1,187	1,339	1,396	1,054	1,234
Market Cap Growth	-8.45%	-11.34%	-4.07%	32.50%	-14.61%	-20.16%
Enterprise Value	1,598	1,742	1,663	1,681	1,427	1,490
Last Close Price	83.63	76.61	85.00	87.60	74.89	86.74

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	472.55	55.04	48.29	76.95	36.00	39.61
Forward PE	27.41	27.67	32.93	34.02	29.15	30.02
PS Ratio	1.55	1.54	2.02	2.33	1.92	2.52
PB Ratio	2.78	1.54	1.76	2.14	2.17	2.73
P/FCF Ratio	19.49	19.47	20.36	19.20	20.95	18.09
P/OCF Ratio	15.04	15.82	17.87	17.03	18.00	16.15
PEG Ratio	2.29	3.27	3.86	4.61	3.24	2.50

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	2.00	2.25	2.50	2.81	2.61	3.04
EV/EBITDA Ratio	15.77	16.90	18.76	19.68	17.68	18.12
EV/EBIT Ratio	20.21	21.59	23.76	24.11	21.63	21.09
EV/FCF Ratio	25.10	28.57	25.29	23.13	28.37	21.85

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.50	0.41	0.39	0.40	0.61	0.49
Debt / EBITDA Ratio	2.34	1.93	2.10	1.93	2.40	1.82
Debt / FCF Ratio	6.02	5.17	4.49	3.56	5.87	3.27
Net Debt / Equity Ratio	0.47	0.36	0.33	0.16	0.54	0.43
Net Debt / EBITDA Ratio	3.52	2.71	2.84	1.21	3.23	2.37
Net Debt / FCF Ratio	5.61	4.57	3.83	1.42	5.19	2.85
Asset Turnover	0.66	0.65	0.61	0.65	0.68	0.73
Quick Ratio	1.13	0.90	1.11	2.20	1.21	1.09
Current Ratio	1.27	1.01	1.18	2.28	1.30	1.14
Return on Equity (ROE)	6.51%	7.59%	6.46%	6.55%	9.26%	13.43%
Return on Assets (ROA)	4.10%	4.25%	4.04%	4.70%	5.13%	6.57%
Return on Invested Capital (ROIC)	5.25%	5.84%	6.00%	7.00%	7.40%	9.73%
Return on Capital Employed (ROCE)	7.00%	7.60%	6.70%	7.80%	8.50%	10.60%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	0.21%	3.33%	2.35%	2.02%	3.05%	3.31%
FCF Yield	5.13%	5.14%	4.91%	5.21%	4.77%	5.53%
Dividend Yield	2.22%	2.35%	2.07%	1.96%	2.19%	1.68%
Payout Ratio	1048.07%	69.13%	84.46%	85.44%	66.30%	45.96%
Buyback Yield / Dilution	-0.18%	-0.74%	-6.17%	-9.26%	-0.68%	-0.49%
Total Shareholder Return	2.01%	1.61%	-4.10%	-7.30%	1.52%	1.19%

SEC Filings: 10-K · 10-Q